Literature DB >> 10482960

Alu-splice cloning of human Intersectin (ITSN), a putative multivalent binding protein expressed in proliferating and differentiating neurons and overexpressed in Down syndrome.

C Pucharcós1, J J Fuentes, C Casas, S de la Luna, S Alcántara, M L Arbonés, E Soriano, X Estivill, M Pritchard.   

Abstract

By Alu-splice PCR we have trapped two exons and subsequently identified the full length cDNA of a human gene, Intersectin (ITSN), which maps to chromosome 21q22.1 between markers D21S320 and D21S325. The gene has the potential to code for at least two different protein isoforms by alternative splicing (ITSN-L and ITSN-S). Intersectin exists with a high degree of similarity in flies, frogs and mammals, suggesting a conserved role in higher eukaryotes. Analysis of the expression pattern of human and mouse Intersectin detected mRNAs in all adult and foetal tissues tested, with the longer isoform present in brain. In situ hybridisation studies in the developing mouse brain showed ITSN expression in both proliferating and differentiating neurons. The genomic structure of ITSN was determined using the chromosome 21 sequences deposited in the public databases. The protein contains several known motifs which implicate ITSN in clathrin mediated endocytosis and synaptic vesicle recycling. The expression pattern of Intersectin in mouse brain, its presumed function and its overexpression in brains from Down syndrome patients, suggest that Intersectin may contribute in a gene dosage-dependent manner to some of the abnormalities of Down syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482960     DOI: 10.1038/sj.ejhg.5200356

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  25 in total

1.  Pleiotropic function of intersectin homologue Cin1 in Cryptococcus neoformans.

Authors:  Gui Shen; Amy Whittington; Kejing Song; Ping Wang
Journal:  Mol Microbiol       Date:  2010-03-16       Impact factor: 3.501

Review 2.  Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines.

Authors:  Peter Penzes; Michael E Cahill
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-12

3.  Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Jessica Gall; Lizzy George; Rachel Nosheny; Michael T Maloney; Ahmad Salehi; William C Mobley
Journal:  Neurobiol Dis       Date:  2011-10-17       Impact factor: 5.996

4.  Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: implications for Down syndrome.

Authors:  Karen T Chang; Kyung-Tai Min
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-21       Impact factor: 11.205

5.  Intersectin-1s: an important regulator of cellular and molecular pathways in lung injury.

Authors:  Dan N Predescu; Cristina Bardita; Rajive Tandon; Sanda A Predescu
Journal:  Pulm Circ       Date:  2013-12-05       Impact factor: 3.017

6.  Synaptic plasticity, a symphony in GEF.

Authors:  Drew D Kiraly; Jodi E Eipper-Mains; Richard E Mains; Betty A Eipper
Journal:  ACS Chem Neurosci       Date:  2010-05-19       Impact factor: 4.418

Review 7.  The endocytic adaptor proteins of pathogenic fungi: charting new and familiar pathways.

Authors:  Ping Wang; Gui Shen
Journal:  Med Mycol       Date:  2011-01-24       Impact factor: 4.076

Review 8.  Control of synapse development and plasticity by Rho GTPase regulatory proteins.

Authors:  Kimberley F Tolias; Joseph G Duman; Kyongmi Um
Journal:  Prog Neurobiol       Date:  2011-04-22       Impact factor: 11.685

9.  Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome.

Authors:  Michael P Hunter; Marianela Nelson; Michael Kurzer; Xuerong Wang; Richard J Kryscio; Elizabeth Head; Graziano Pinna; John P O'Bryan
Journal:  Neuroreport       Date:  2011-10-26       Impact factor: 1.837

Review 10.  Intersecting pathways in cell biology.

Authors:  John P O'Bryan
Journal:  Sci Signal       Date:  2010-12-14       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.